Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Managed Healthcare Industry Analysis

UpdatedOct 01, 2025
DataAggregated Company Financials
Companies11
  • 7D-0.03%
  • 3M6.7%
  • 1Y-38.2%
  • YTDn/a

Last week, the Managed Healthcare industry hasn't moved much but Centene is up 8.9% in that time. Unfortunately though, the industry is down 38% over the past 12 months. Earnings are forecast to grow by 7.9% annually.

Industry Valuation and Performance

Has the U.S. Managed Healthcare Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Oct 2025US$458.2bUS$944.0bUS$31.5b14.1x14.5x0.5x
Fri, 29 Aug 2025US$418.6bUS$943.9bUS$31.5b12.9x13.3x0.4x
Sun, 27 Jul 2025US$385.8bUS$937.5bUS$32.4b11.9x11.9x0.4x
Tue, 24 Jun 2025US$443.4bUS$913.9bUS$34.4b13.8x12.9x0.5x
Thu, 22 May 2025US$479.9bUS$913.9bUS$34.4b15x14x0.5x
Sat, 19 Apr 2025US$605.6bUS$897.4bUS$33.8b17.4x17.9x0.7x
Mon, 17 Mar 2025US$634.3bUS$887.6bUS$26.1b20.6x24.3x0.7x
Wed, 12 Feb 2025US$676.7bUS$888.2bUS$26.0b20.4x26x0.8x
Fri, 10 Jan 2025US$667.2bUS$873.5bUS$26.2b19.4x25.4x0.8x
Sun, 08 Dec 2024US$687.8bUS$873.5bUS$26.2b18.3x26.2x0.8x
Tue, 05 Nov 2024US$715.7bUS$873.5bUS$26.2b19.2x27.3x0.8x
Thu, 03 Oct 2024US$770.7bUS$855.9bUS$26.3b19.3x29.3x0.9x
Sat, 31 Aug 2024US$790.1bUS$855.8bUS$26.3b22.1x30.1x0.9x
Mon, 29 Jul 2024US$764.5bUS$852.8bUS$26.5b21.1x28.8x0.9x
Wed, 26 Jun 2024US$686.2bUS$844.2bUS$27.2b20.7x25.2x0.8x
Fri, 24 May 2024US$723.6bUS$844.1bUS$27.2b20.8x26.6x0.9x
Sun, 21 Apr 2024US$698.3bUS$837.8bUS$27.6b19.8x25.3x0.8x
Tue, 19 Mar 2024US$686.9bUS$829.5bUS$34.4b20x20x0.8x
Thu, 15 Feb 2024US$717.8bUS$832.8bUS$33.3b20.6x21.6x0.9x
Sat, 13 Jan 2024US$724.3bUS$823.4bUS$33.5b20.2x21.6x0.9x
Mon, 11 Dec 2023US$752.3bUS$809.0bUS$33.9b21.4x22.2x0.9x
Wed, 08 Nov 2023US$729.3bUS$808.9bUS$33.9b21.4x21.5x0.9x
Fri, 06 Oct 2023US$711.2bUS$789.4bUS$34.2b21x20.8x0.9x
Sun, 03 Sep 2023US$664.7bUS$789.4bUS$34.2b19.8x19.5x0.8x
Tue, 01 Aug 2023US$705.8bUS$786.5bUS$33.8b19.4x20.9x0.9x
Thu, 29 Jun 2023US$664.5bUS$767.3bUS$31.9b21.3x20.8x0.9x
Sat, 27 May 2023US$676.3bUS$767.3bUS$31.9b21.7x21.2x0.9x
Mon, 24 Apr 2023US$680.9bUS$763.3bUS$31.2b21.9x21.8x0.9x
Wed, 22 Mar 2023US$683.1bUS$747.4bUS$30.4b22.3x22.4x0.9x
Fri, 17 Feb 2023US$702.7bUS$747.4bUS$30.3b22.5x23.2x0.9x
Sun, 15 Jan 2023US$707.3bUS$738.5bUS$31.4b21.7x22.5x1x
Tue, 13 Dec 2022US$785.5bUS$729.4bUS$30.7b24.4x25.6x1.1x
Thu, 10 Nov 2022US$778.7bUS$731.6bUS$30.7b23.6x25.4x1.1x
Sat, 08 Oct 2022US$723.2bUS$711.2bUS$29.5b23x24.5x1x
Price to Earnings Ratio

24.5x


Total Market Cap: US$723.2bTotal Earnings: US$29.5bTotal Revenue: US$711.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Managed Healthcare Industry Price to Earnings3Y Average 22.3x202320242025
Current Industry PE
  • Investors are pessimistic on the American Managed Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.5x which is lower than its 3-year average PE of 22.3x.
  • The industry is trading close to its 3-year average PS ratio of 0.82x.
Past Earnings Growth
  • The earnings for companies in the Managed Healthcare industry have grown 2.2% per year over the last three years.
  • Revenues for these companies have grown 9.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Managed Healthcare compare with similar industries?

US Market0.22%
Healthcare1.38%
Healthcare Services0.22%
Managed Healthcare-0.025%
Healthcare Facilities3.41%
Healthcare Distributors2.31%
Healthcare Services-0.60%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CNC CenteneUS$35.688.9%
+US$1.4b		-51.7%PE8.5x
MOH Molina HealthcareUS$191.364.8%
+US$477.0m		-44.0%PE9.2x
HUM HumanaUS$260.170.7%
+US$222.5m		-6.9%PE19.9x
ALHC Alignment HealthcareUS$17.452.4%
+US$81.2m		74.5%PS1x
HQY HealthEquityUS$94.771.0%
+US$79.3m		18.1%PE56x

Latest News

ELV
US$323.12
Elevance Health
7D
-0.2%
1Y
-36.8%
CNC
US$35.68
Centene
7D
8.9%
1Y
-51.7%
HQY
US$94.77
HealthEquity
7D
1.0%
1Y
18.1%
UNH
US$345.30
UnitedHealth Group
7D
-0.7%
1Y
-40.8%

Medicare Shifts And Digital Tools Will Secure Future Performance

Analysts have raised UnitedHealth Group’s price target to $342.58, citing stronger-than-expected Medicare Advantage Star ratings, reinforced management guidance, and improved sector sentiment, though some remain cautious given ongoing regulatory risks and near-term earnings uncertainty. Analyst Commentary Bullish analysts raised price targets on UnitedHealth as recent Medicare Advantage Star ratings results (with 78% of MA members in 4+ Star plans) came in better than feared, easing investor concerns about future reimbursement levels and supporting multi-year margin improvement.
MOH
US$191.36
Molina Healthcare
7D
4.8%
1Y
-44.0%

Winning RFPs And Medicaid Adjustments Will Secure Future Healthcare Success

Despite increased implementation and margin risks tied to stricter CMS Star ratings, sector cost trends, and uncertain legislative impacts, analysts have modestly raised their fair value estimate for Molina Healthcare from $196.71 to $202.43. Analyst Commentary Stricter CMS Star rating cut points for 2026 are expected to challenge managed care organizations' ability to maintain high-rated plans, potentially impacting payment and competitiveness.
HUM
US$260.17
Humana
7D
0.7%
1Y
-6.9%
CLOV
US$3.06
Clover Health Investments
7D
-5.8%
1Y
10.1%
ALHC
US$17.45
Alignment Healthcare
7D
2.4%
1Y
74.5%
PGNY
US$21.52
Progyny
7D
0.2%
1Y
33.0%

Rising Demand For Women's Health Will Transform Market Opportunity

Analysts cite improving membership trends, positive pre-announcements, and strategic partnerships expanding Progyny's women's health services as driving renewed confidence and modest upgrades, though the consensus price target remains unchanged at $28.25. Analyst Commentary Bullish analysts cite a rebound in membership activity, highlighted by two consecutive positive pre-announcements, as signaling recovery from last year's lows and renewed momentum.
NEUE
US$6.67
NeueHealth
7D
-1.4%
1Y
26.1%